Geneuro
GEM | PA
Overview
Corporate Details
- ISIN(s):
- CH0308403085
- LEI:
- 213800FUJCKXO9LK3444
- Country:
- Switzerland
- Address:
- chemin du Pré-Fleuri 3, 1228 Plan-les-Ouates
- Website:
- https://geneuro.ch/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
GeNeuro is a Swiss-based, clinical-stage biopharmaceutical company focused on developing treatments for neurodegenerative and autoimmune diseases. The company utilizes a novel therapeutic approach that targets pathogenic proteins encoded by human endogenous retroviruses (HERVs), which are believed to contribute to the progression of diseases such as Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), and post-COVID conditions. Its main drug candidate, temelimab, is being developed to treat the cognitive and fatigue symptoms associated with Long COVID. In July 2024, the company was granted a debt-restructuring moratorium.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Geneuro.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-30 19:37 |
Post-Annual General Meeting Information
Inside Information / Other news releases
|
English | 224.5 KB | |
| 2025-06-30 19:37 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 753.1 KB | |
| 2025-06-12 22:42 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 204.9 KB | |
| 2025-06-12 22:42 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 203.8 KB | |
| 2025-06-10 18:24 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 207.4 KB | |
| 2025-06-10 18:24 |
Pre-Annual General Meeting Information
Inside Information / Other news releases
|
English | 209.5 KB | |
| 2025-05-27 18:00 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 162.5 KB | |
| 2025-05-27 18:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 187.1 KB | |
| 2025-05-12 18:36 |
Report Publication Announcement
Inside Information / Other news releases
|
English | 481.8 KB | |
| 2025-05-12 18:36 |
Report Publication Announcement
Informations privilégiées / Autres communiqués
|
French | 669.5 KB |
Automate Your Workflow. Get a real-time feed of all Geneuro filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Geneuro via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
